5Feldman B M, Funk S, Lundin B. Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)[J]. Haemophilia, 2008, 14 (S3): 162-169. 被引量：1
6Hilgartner M W. Current treatment of hemophilic arthropathy[J]. Curr Opin Pediatr, 2002, 14(1): 46-49. 被引量：1
7Rand T, Trattnig S, Male C, et al. Magnetic resonance imaging in hemophilic children: value of gradient echo and contrast-enhance imaging[J]. Magn Reson Imaging,1999,17(2): 199-205. 被引量：1
8Coppola A, Tagliaferri A, Di C M, et al. Prophylaxis in children with hemophilia: evidence-based achievements, old and new challenges[J]. Semin Thromb Hemost,2012, 38(1):79-94. 被引量：1
9Wang T,Zhang L,Li H, et al.Assessing health related quality-of-life in individuals with haemophilia in China[J].Haemophilia,2004, 10(4):370-375. 被引量：1
10Rodriguez-Nerchan E C, Jimenez-Yuste V, Aznar J A, et al. Joint protection in haemophilia[J]. Haemophilia,2011, 17 (S 2): 1-23. 被引量：1
